Depsipeptide (FR901228) enhances the cytotoxic activity of TRAIL by redistributing TRAIL receptor to membrane lipid rafts (Q46383982)

21 December 2017

title

Depsipeptide (FR901228) enhances the cytotoxic activity of TRAIL by redistributing TRAIL receptor to membrane lipid rafts (English)

1 reference

21 December 2017

0 references

1 reference

Rebecca L Vanoosten

1

1 reference

21 December 2017

Jill M Moore

series ordinal

2

1 reference

21 December 2017

Aaron T Ludwig

series ordinal

3

1 reference

21 December 2017

Thomas S Griffith

series ordinal

4

1 reference

21 December 2017

publication date

1 April 2005

1 reference

21 December 2017

published in

Molecular Therapy

1 reference

21 December 2017

volume

11

1 reference

21 December 2017

issue

4

1 reference

21 December 2017

page(s)

542-552

1 reference

21 December 2017

Gene therapy progress and prospects: adenoviral vectors

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

Systemic Delivery of Insulin via an Enhancer-Free Ocular Device

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

Local delivery of chemotherapy: a supplement to existing cancer treatments. A case for surgical pastes and coated stents.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

Viral vector delivery in solid-state vehicles: gene expression in a murine prostate cancer model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

Histone deacetylases, transcriptional control, and cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

Histone deacetylases and cancer: causes and therapies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

Histone deacetylase inhibitors as new cancer drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

FR901228, a potent antitumor antibiotic, is a novel histone deacetylase inhibitor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

Histone-deacetylase inhibitors: novel drugs for the treatment of cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

FR901228, a novel antitumor bicyclic depsipeptide produced by Chromobacterium violaceum No. 968. III. Antitumor activities on experimental tumors in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

Histone deacetylase inhibitor FK228 inhibits tumor angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

A phase I trial of depsipeptide (FR901228) in patients with advanced cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

A novel combination of suicide gene therapy and histone deacetylase inhibitor for treatment of malignant melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

Amplification of transgene expression in vitro and in vivo using a novel inhibitor of histone deacetylase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

Adenoviral-mediated transfer of the TNF-related apoptosis-inducing ligand/Apo-2 ligand gene induces tumor cell apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

Suppression of tumor growth following intralesional therapy with TRAIL recombinant adenovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

Identification and characterization of a new member of the TNF family that induces apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

The topoisomerase I inhibitor topotecan increases the sensitivity of prostate tumor cells to TRAIL/Apo-2L-induced apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

The histone deacetylase inhibitor suberic bishydroxamate: a potential sensitizer of melanoma to TNF-related apoptosis-inducing ligand (TRAIL) induced apoptosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

Sensitization of mesothelioma to TRAIL apoptosis by inhibition of histone deacetylase: role of Bcl-xL down-regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

Interleukin 1 beta-converting enzyme related proteases/caspases are involved in TRAIL-induced apoptosis of myeloma and leukemia cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

Depsipeptide (FR901228) induces histone acetylation and inhibition of histone deacetylase in chronic lymphocytic leukemia cells concurrent with activation of caspase 8-mediated apoptosis and down-regulation of c-FLIP protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

CD95 Signaling via Ceramide-rich Membrane Rafts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

An essential role for membrane rafts in the initiation of Fas/CD95-triggered cell death in mouse thymocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

Ligand-independent redistribution of Fas (CD95) into lipid rafts mediates clonotypic T cell death.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

Location is everything: lipid rafts and immune cell signaling.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

Redistribution of CD95, DR4 and DR5 in rafts accounts for the synergistic toxicity of resveratrol and death receptor ligands in colon carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

Aggregation of lipid rafts accompanies signaling via the T cell antigen receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

Adenoviruses in oncology: a viable option?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

Cooperative therapeutic effects of androgen ablation and adenovirus-mediated herpes simplex virus thymidine kinase gene and ganciclovir therapy in experimental prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

Adenovirus-mediated interleukin-12 gene therapy for prostate cancer: suppression of orthotopic tumor growth and pre-established lung metastases in an orthotopic model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

Adenovirus-mediated interferon-beta gene therapy suppresses growth and metastasis of human prostate cancer in nude mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

Induction of cell cycle arrest and apoptosis in human prostate carcinoma cells by a recombinant adenovirus expressing p27(Kip1).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

7 January 2021

Gene therapy for cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

Acetylation of general transcription factors by histone acetyltransferases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

Regulation of activity of the transcription factor GATA-1 by acetylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

Effects of FK228, a novel histone deacetylase inhibitor, on human lymphoma U-937 cells in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

Apoptosis: a link between cancer genetics and chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

FR901228 induces tumor regression associated with induction of Fas ligand and activation of Fas signaling in human osteosarcoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

Acceleration of human neutrophil apoptosis by TRAIL.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

TRAIL/Apo-2 ligand induces primary plasma cell apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

The apoptotic ligands TRAIL, TWEAK, and Fas ligand mediate monocyte death induced by autologous lupus T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

Tumor necrosis factor-related apoptosis-inducing ligand induces neuronal death in a murine model of HIV central nervous system infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

Activated stellate cells express the TRAIL receptor-2/death receptor-5 and undergo TRAIL-mediated apoptosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

CD40 signaling in human dendritic cells is initiated within membrane rafts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

Restricted localization of the TNF receptor CD120a to lipid rafts: a novel role for the death domain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

A simple method for the rapid generation of recombinant adenovirus vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

Comparison of in vitro cell cytotoxic assays for tumor necrosis factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.008

10.1016/J.YMTHE.2004.12.008

7 January 2021

Identifiers

DOI

1 reference

21 December 2017

1 reference

21 December 2017